It would also have been interesting to correlate GAS5-derived snoRNA levels with outcome in these patients, however as these samples were all taken from patients with resectable Dukes Stage A–C tumours there has not been a significant gap since their diagnosis to accrue statistically meaningful results as the data are too immature. Here, GAS5 is linked to neoplasm.